REFERENCES
- Hashimoto T, Hamauzu N, Honma M et al.: Histo-pathological examination of a case of Behcet’s disease with aortic regurgitation. Jpn J Rheumatol 31: 62–67, 1991 (in Japanese).
- Tasdemir I, Sivri B, Turgan C et al.: The expanding spectrum of a disease: Behcet’s disease associated with amyloidosis. Nephron 52: 154–157, 1989.
- Gamble CN, Wiesner KB, Shapiro RF et al.: The immune complex pathogenesis of glomerulonephritis and pulmonary vasculitis in Behcet’s disease. Am J Med 66: 1031–1039, 1979.
- Miura M, Tornino Y, Suga T et al.: A case of Behcet’s disease associated with membranous nephropathy. Tokai J Exp Clin Med 9: 231–235, 1984.
- Malik GH, Sirwal IA, Pandit KA: Behcet’s syndrome associated with minimal change glomerulonephritis and renal vein thrombosis. Nephron 52: 87–89, 1989.
- Peces R, Riesgo I, Ortega F et ai: Amyloidosis in Behcet’s disease. Nephron 36: 114–117, 1984.
- Moorhead JF, Chan MK, El-Nahas M et al.: Lipid nephrotoxicity in chronic progressive glomerular and tubulointerstitial disease. Lancet 2: 1309–1311, 1982.
- Onbe T, Makino H, Haramoto T et al.: Effect of protease inhibitor on primary glomerulonephritis and the mechanism of the effect. Jpn J Nephrol 753–759, 1991 (in Japanese).
- Tojo S, Yoshri K, Nagasawa T et al.: Clinical effect of kampo medicine extract granules for ethical use; Sairei-to (TJ-114) in chronic glomerulonephritis and nephrotic syndrome (The first report). A multi-center open study. Kidney and Dialysis 31: 113–125, 1991 (in Japanese).